EVO301 not checked

Evommune, Inc.

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Atopic Dermatitis (AD), Eczema, Eczema Atopic Dermatitis
Main trialPhase 2
“This is a Phase 2a efficacy and safety study of EVO301 for the treatment of adults with atopic dermatitis.”In the company’s words, NCT06723405 on ClinicalTrials.gov

Other drugs for Atopic Dermatitis (AD)

All 90 drugs for Atopic Dermatitis (AD)

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed 17 Nov 2025 Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow EVO301

Following is part of Solo: you see every change to EVO301 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in